Because generic drugs sold in the U.S. must be FDA-approved, healthcare providers and patients assume that they are safe and effective. There is growing evidence that this confidence may be misplaced. Authors Rosemary Gibson and Arthur L. Kellermann co-authored a Health Affairs Journal article about what physicians and health systems can do to minimize the risk of substandard generic medicines.
Because generic drugs sold in the U.S. must be FDA-approved, healthcare providers and patients assume that they are safe and effective. There is growing evidence that this confidence may be misplaced. Authors Rosemary Gibson and Arthur L. Kellermann co-authored a Health Affairs Journal article about what physicians and health systems can do to minimize the risk of substandard generic medicines.
Because generic drugs sold in the U.S. must be FDA-approved, healthcare providers and patients assume that they are safe and effective. There is growing evidence that this confidence may be misplaced. Authors Rosemary Gibson and Arthur L. Kellermann co-authored a Health Affairs Journal article about what physicians and health systems can do to minimize the risk of substandard generic medicines.
Because generic drugs sold in the U.S. must be FDA-approved, healthcare providers and patients assume that they are safe and effective. There is growing evidence that this confidence may be misplaced. Authors Rosemary Gibson and Arthur L. Kellermann co-authored a Health Affairs Journal article about what physicians and health systems can do to minimize the risk of substandard generic medicines.
